1. Venniyoor, A., 2017. The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: More questions than answers. Chin. J. Cancer, Vol. 36. 10.1186/s40880-017-0185-8.
   CrossRef  |  Direct Link  |  
2. Venniyoor, A., 2017. Pembrolizumab for advanced urothelial carcinoma. N. Engl. J. Med., 376: 2302-2304.
   CrossRef  |  Direct Link  |  
3. Venniyoor, A., 2017. False-negative MRI findings for leptomeningeal metastases with use of bevacizumab. J. Thoracic Oncol., 12: e5-e5.
   CrossRef  |  Direct Link  |  
4. Essam, A.M., A. Venniyoor, S. Nagdev, I. Mehdi and B. Al Bahrani, 2017. Long-term survival in a case of metastatic papillary renal cell carcinoma. S. Asian J. Cancer, 6: 19-19.
   CrossRef  |  Direct Link  |  
5. Venniyoor, A., A.M. Essam, F. Ramadhan, H. Keswani, I. Mehdi and B.A. Bahrani, 2016. High occurrence of non-clear cell renal cell carcinoma in Oman. Asian Pac. J. Cancer Prev., 17: 2801-2804.
   PubMed  |  Direct Link  |  
6. Venniyoor, A., 2016. Prostate cancer is not breast cancer. Indian J. Med Pediatr. Oncol., 37: 4-5.
   CrossRef  |  Direct Link  |  
7. Venniyoor, A., 2016. Immune checkpoint inhibitors for Indian patients: A note of caution. Indian J. Cancer, 53: 468-469.
   CrossRef  |  Direct Link  |  
8. Venniyoor, A., 2016. Early intervention in lung cancers with rapid plasma genotyping for EGFR and KRAS mutations. JAMA Oncol., 2: 1096-1096.
   CrossRef  |  Direct Link  |  
9. Venniyoor, A. and B. Al Bahrani, 2016. Minocycline improves the efficacy of EGFR inhibitor therapy: A hypothesis. Front. Oncol., Vol. 6. 10.3389/fonc.2016.00231.
   CrossRef  |  Direct Link  |  
10. Venniyoor, A., B. Al Bahrani and B. Rajan, 2014. The dilemma of Serum Tumor Marker (STM) flares. Gulf J. Oncol., 15: 63-67.
    PubMed  |  Direct Link  |  
11. Venniyoor, A., 2014. Deciding site of biopsy at metastatic relapse. Therapeut. Adv. Med. Oncol., 6: 305-305.
    CrossRef  |  Direct Link  |  
12. Venniyoor, A., 2012. Nomenclature for drugs in targeted therapies. Med. Hypotheses, 79: 118-119.
    CrossRef  |  Direct Link  |  
13. Malik, A., A. Veniyoor, B. Fanthome and V. Dutta, 2012. Follicular dendritic cell sarcoma: A diagnostic challenge! J. Cancer Res. Therapeut., 8: 306-307.
    CrossRef  |  Direct Link  |  
14. Venniyoor, A., 2011. Shorter course of trastuzumab: Caveat emptor. Indian J. Med. Paediatr. Oncol., 32: 55-56.
    CrossRef  |  Direct Link  |  
15. Venniyoor, A., 2011. Adjuvant docetaxel for node-negative breast cancer. N. Engl. J. Med., 364: 976-978.
    CrossRef  |  Direct Link  |  
16. Venniyoor, A., 2010. Personal reflection: Remembrance. J. Palliative Med., 13: 1153-1153.
17. Venniyoor, A., 2010. A proposal to rename and classify aplastic anemia as Myeloaplastic Syndrome (MAS) type I and II. Med. Hypotheses, 74: 1085-1086.
18. Venniyoor, A., 2008. Cancer of gallbladder and cholesterol gallstones: Molecular links. Med. Hypothesis, 70: 646-646.
19. Rangaraju, R.R., K. Anil, A. Venniyoor, H. Singh, S. Ranjan and B. Kapur, 2008. Unusual responses to thalidomide in refractory solid tumors. Asia-Pac. J. Clin. Oncol., 4: 113-117.
    CrossRef  |  Direct Link  |  
20. Venniyoor, A., 2006. Gastric lymphoma, Helicobacter pylori and gastric amyloidosis. Indian J. Gastroenterol., 25: 105-105.
21. Singh, H.P., R. Ranga Rao, V. Nair and A.J. Venniyoor, 2005. Pediatric acute myeloid leukemia: Experience with an intensive chemotherapy protocol-a pilot study. Indian J. Med. Paediatr. Oncol., 26: 10-14.
22. Ranga Rao, R., A.J. Venniyoor and H.P. Singh, 2004. Adjuvant therapy of early ovarian cancer. Indian J. Med. Paediatr. Oncol., 25: 18-20.
    Direct Link  |